Pemetrexed Plus Cisplatin vs Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer
J. Clin. Oncol 2020 May 14;[EPub Ahead of Print], H Kenmotsu, N Yamamoto, T Yamanaka, K Yoshiya, T Takahashi, T Ueno, K Goto, H Daga, N Ikeda, K Sugio, T Seto, S Toyooka, H Date, T Mitsudomi, I Okamoto, K Yokoi, H Saka, H Okamoto, Y Takiguchi, M TsuboiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.